Developing a Toolbox of Functional Bioassays for Optimizing ADCC

In a new article, Anke Hartung, Ph.D., Associate Director of Bioassay Development at Tanvex CDMO, presents a case study showcasing Tanvex CDMO's tailored approach to confirming biosimilar functionality. Key highlights:  
  • Detailed Glycan Analysis in Biosimilar Development
  • Enhanced Assay Development for Functional Evaluation of Biosimilars
  • Comprehensive Platform Solution for Fc Binding Assays

Access the article

"*" indicates required fields

Name
Subscribe
This field is for validation purposes and should be left unchanged.